Christof Stamm

Cardiac cell therapy: a realistic concept for elderly patients?

Cell therapy for heart disease: great expectations, as yet unmet.

A heart full of stem cells: the spectrum of myocardial progenitor cells in the postnatal heart.

Clinical application of stem cells in the cardiovascular system.

Impact of heart failure on the behavior of human neonatal stem cells in vitro.

Autologous CD133+ bone marrow cells and bypass grafting for regeneration of ischaemic myocardium: the Cardio133 trial.

Mechanisms of paracrine cardioprotection by cord blood mesenchymal stromal cells.

Human cardiac extracellular matrix supports myocardial lineage commitment of pluripotent stem cells.

Susceptibility of murine induced pluripotent stem cell-derived cardiomyocytes to hypoxia and nutrient deprivation.

Vent-induced prosthetic leaflet thrombosis treated by open-heart valve-in-valve implantation.

Decellularized amniotic membrane attenuates postinfarct left ventricular remodeling.

The cytoprotective capacity of processed human cardiac extracellular matrix.

Re: 'Two minds with but a single thought …'.

Cardiac Function Improvement and Bone Marrow Response -: Outcome Analysis of the Randomized PERFECT Phase III Clinical Trial of Intramyocardial CD133(+) Application After Myocardial Infarction.